Merchenthaler, Istvan
Lane, Malcolm
Sabnis, Gauri
Brodie, Angela
Nguyen, Vien
Prokai, Laszlo
Prokai-Tatrai, Katalin
Article History
Received: 16 December 2015
Accepted: 6 July 2016
First Online: 1 August 2016
Competing interests
: L.P. and K.P.-T. are inventors in the patents covering the use of 10β,17β-dihydroxyestra-1,4-dien-3-one as a bioprecursor prodrug of 17β-estradiol and are co-founders of AgyPharma LLC with equity in the company that licensed the patents. I.M., M.L., G.S., A.B. and V.N. declare no competing financial interests.